Company news
Jade Biosciences, Inc. news in 2023
Jade Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
November 19, 2023
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
November 12, 2023
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
August 13, 2023
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
July 10, 2023
Aerovate Therapeutics to Present at Jefferies Global Healthcare Conference
May 31, 2023
Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International Conference
May 21, 2023
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 14, 2023
Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights
March 28, 2023
Aerovate Therapeutics to Present at Cowen 43rd Annual Health Care Conference
March 1, 2023
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
January 22, 2023